Form 4: Director Jian Sun Executes RSU Sales for Tax Obligations
Statement of Changes in Beneficial Ownership
Director Jian Sun sold 99,720 Class A ordinary shares of 111, Inc. to satisfy tax withholding obligations following RSU vesting.
Summary
- Director Jian Sun reported the acquisition of 791,905 RSUs across two grants in May 2026.
- The reporting person sold a total of 99,720 Class A ordinary shares (equivalent to 4,986 ADSs) on May 26 and May 27, 2026.
- The sales were executed at prices of $0.27 and $0.25 per share.
- The transactions were conducted specifically to satisfy tax withholding obligations related to the vesting of RSUs.
- Following these transactions, the reporting person maintains a beneficial ownership of 710,551 Class A ordinary shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the share sales were purely administrative and mandated by tax requirements rather than discretionary trading.
Positives
- The director continues to hold a significant equity stake of 710,551 shares in the company.
- The transactions were routine administrative actions related to tax obligations rather than discretionary market selling.
Negatives
- The sale of shares, even for tax purposes, reduces the direct ownership stake of a key director.
- The transaction prices of $0.25 to $0.27 per share reflect a low valuation for the company's equity.
Risks
- Continued reliance on equity-based compensation may lead to further dilution or future tax-related selling pressure.
- The low trading price of the underlying securities may impact investor sentiment regarding the company's valuation.
Future Outlook
The filing does not provide forward-looking business guidance, as it is a disclosure of insider transaction activity.
Management Comments
- The transactions were executed to satisfy tax withholding obligations in connection with the vesting of RSUs.
Industry Context
StockSavvy.ai notes that insider sales for tax withholding are standard corporate governance practices and generally do not signal a lack of confidence in the company's long-term prospects.
Comparison to Industry Standards
- The use of 'sell-to-cover' transactions to satisfy tax obligations is a standard practice among executives in the technology and healthcare sectors.
- The vesting schedule of 25% annually over four years is consistent with standard equity incentive plans for public company directors.
Stakeholder Impact
- Shareholders should view this as a routine administrative event with no material impact on company operations.
Next Steps
- Future vesting of the remaining 413,168 RSUs granted on May 12, 2026, subject to the four-year vesting schedule.
Key Dates
| Date | Description |
|---|---|
| 09/12/2018 | Initial RSU grant date |
| 05/11/2026 | Grant date for 378,737 RSUs |
| 05/12/2026 | Grant date and vesting commencement for 413,168 RSUs |
| 05/26/2026 | Earliest transaction date for share sales |
| 05/27/2026 | Final transaction date for share sales |
| 05/29/2026 | Filing date of the Form 4 |
Keywords
111 Inc, YI, Form 4, Insider Trading, RSU, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.